The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response

Immunotherapy ◽  
2014 ◽  
Vol 6 (5) ◽  
pp. 519-531 ◽  
Author(s):  
Erika J Schneble ◽  
John S Berry ◽  
Francois A Trappey ◽  
Guy T Clifton ◽  
Sathibalan Ponniah ◽  
...  
Keyword(s):  
Breast Cancer ◽  
At Risk ◽  
Clinical Response ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Patients At Risk

scholarly journals Cost-Effectiveness of Primary Pegfilgrastim Prophylaxis in Breast Cancer Patients at Risk of Febrile Neutropenia

2012 ◽  
Vol 23 ◽  
pp. ix501
Author(s):  
M.J. Aarts ◽  
J.P. Grutters ◽  
F.P. Peters ◽  
C.M. Mandigers ◽  
M.W. Dercksen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
At Risk ◽  
Cost Effectiveness ◽  
Febrile Neutropenia ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Patients At Risk

Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence – Implications for vaccine trial design

2018 ◽  
Vol 195 ◽  
pp. 28-35 ◽  
Author(s):  
Doreen O. Jackson ◽  
Francois A. Trappey ◽  
G. Travis Clifton ◽  
Timothy J. Vreeland ◽  
Kaitlin M. Peace ◽  
...  
Keyword(s):  
Breast Cancer ◽  
At Risk ◽  
Cancer Patients ◽  
Trial Design ◽  
Vaccine Trial ◽  
Her2 Status ◽  
Breast Cancer Patients ◽  
Patients At Risk

scholarly journals Mammostrat®as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

2010 ◽  
Vol 12 (4) ◽  
Author(s):  
John MS Bartlett ◽  
Jeremy Thomas ◽  
Douglas T Ross ◽  
Robert S Seitz ◽  
Brian Z Ring ◽  
...  
Keyword(s):  
Breast Cancer ◽  
At Risk ◽  
Cancer Patients ◽  
Endocrine Therapy ◽  
Breast Cancer Patients ◽  
Risk Of Recurrence ◽  
Patients At Risk

Can Proton Therapy Improve the Therapeutic Ratio in Breast Cancer Patients at Risk for Nodal Disease?

2014 ◽  
Vol 37 (6) ◽  
pp. 568-574 ◽  
Author(s):  
Natalie Xu ◽  
Meng Wei Ho ◽  
Zuofeng Li ◽  
Christopher G. Morris ◽  
Nancy P. Mendenhall
Keyword(s):  
Breast Cancer ◽  
At Risk ◽  
Cancer Patients ◽  
Proton Therapy ◽  
Breast Cancer Patients ◽  
Nodal Disease ◽  
Therapeutic Ratio ◽  
Patients At Risk

scholarly journals TGF-?1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis

1999 ◽  
Vol 84 (2) ◽  
pp. 155-159 ◽  
Author(s):  
Chenggang Li ◽  
Philip B. Wilson ◽  
Edward Levine ◽  
Jim Barber ◽  
Alan L. Stewart ◽  
...  
Keyword(s):  
Breast Cancer ◽  
At Risk ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Patients At Risk ◽  
Pre Treatment
Sign in / Sign up

Export Citation Format

Share Document